Annual report
7732.TEDINET S100VZAD
Period2024-04-01 → 2025-03-31
Filed2025-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥216.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥216.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥215.6bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥176.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥137.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥8.8bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥11.2bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.7bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.9bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.8bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.8bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.6bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.4bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥417m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.9bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.8bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.7bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥659m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥5.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥249.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥247.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥207.9bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥185.0bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥168.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥144.3bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥136.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥104.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥110.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥97.0bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥85.2bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥70.7bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥19.6bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥18.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥20.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥9.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥20.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥19.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥15.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥26.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥8.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥18.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.9bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥13.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥3.96 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.9 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.16 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.71 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.59 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥3.96 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.89 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥112.15 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.69 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.59 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥980.39 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,027.99 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥905.17 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥793.57 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥659.31 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 41.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.8% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.1% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 0.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.2% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.0% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 5,327 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 5,556 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 5,543 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 5,248 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 4,955 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥57.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥56.8bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥55.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥49.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥40.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.2bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥4.8bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥8.9bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.6bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.1bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.7bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥984m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.9bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥10.5bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥7.8bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥9.2bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥8.3bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥917m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥155.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥146.8bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥124.0bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥119.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥121.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥85.2bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥79.5bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥70.4bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥67.3bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥61.8bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥58.2bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥53.0bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.0bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥513m | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥73.76 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.91 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.48 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71.79 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.72 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥73.73 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥86.89 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.47 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥71.77 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥36 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥667.22 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥638.05 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥586.29 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥552.68 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥503.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 45.2% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.8% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.3% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.6% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 108,382,642 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 108,322,242 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 108,265,842 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 108,179,842 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 108,156,842 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 830 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 749 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 718 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 678 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 654 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 73
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2024-04-01 → 2025-03-31 | ¥304m |
| Otherother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥245m |
| Otherother segments | employees | at 2025-03-31 | 263 pure |
| Otherother segments | revenue | 2024-04-01 → 2025-03-31 | ¥435m |
| Otherother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥434m |
| Otherother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥0 |
| Otherother segments | segment assets | at 2025-03-31 | ¥771m |
| Otherother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥106m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥106m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥4.3bn |
| Eye Care Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥4.3bn |
| Eye Care Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3.1bn |
| Eye Care Businessreportable segment | employees | at 2025-03-31 | 2171 pure |
| Eye Care Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥84.3bn |
| Eye Care Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥84.2bn |
| Eye Care Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥105m |
| Eye Care Businessreportable segment | segment assets | at 2025-03-31 | ¥68.2bn |
| Eye Care Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥8.5bn |
| Positioning Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥7.8bn |
| Positioning Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥7.5bn |
| Positioning Businessreportable segment | employees | at 2025-03-31 | 2893 pure |
| Positioning Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥131.4bn |
| Positioning Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥131.4bn |
| Positioning Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥0 |
| Positioning Businessreportable segment | segment assets | at 2025-03-31 | ¥177.4bn |
| Positioning Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥6.0bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥10.9bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥216.1bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥216.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥106m |
| —segment total | segment assets | at 2025-03-31 | ¥246.4bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥13.2bn |
| Otherother segments | capex | 2023-04-01 → 2024-03-31 | ¥204m |
| Otherother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥295m |
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Otherother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥3m |
| Otherother segments | segment assets | at 2024-03-31 | ¥263m |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥177m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥1.5bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥228m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥228m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥4.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥4.4bn |
| Eye Care Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥4.6bn |
| Eye Care Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| Eye Care Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥75.2bn |
| Eye Care Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥75.0bn |
| Eye Care Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥218m |
| Eye Care Businessreportable segment | segment assets | at 2024-03-31 | ¥62.7bn |
| Eye Care Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥6.7bn |
| Positioning Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥11.3bn |
| Positioning Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Positioning Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥140.4bn |
| Positioning Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥140.4bn |
| Positioning Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥6m |
| Positioning Businessreportable segment | segment assets | at 2024-03-31 | ¥179.8bn |
| Positioning Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥9.1bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥16.1bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥10.7bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥216.7bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥216.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥228m |
| —segment total | segment assets | at 2024-03-31 | ¥242.8bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥15.6bn |
| Eye Care Businessreportable segment | employees | at 2025-03-31 | 400 pure |
| Positioning Businessreportable segment | employees | at 2025-03-31 | 430 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,723
| Item | Context | Value | Unit |
|---|---|---|---|
| Research and development expenses research and development activities | CurrentYearDuration | 25147000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_CorporateSharedMember | 2126000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02299-000PositioningBusinessReportableSegmentMember | 18284000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02299-000EyeCareBusinessReportableSegmentMember | 4182000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 6791000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02299-000PositioningBusinessReportableSegmentMember | 3789000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02299-000EyeCareBusinessReportableSegmentMember | 2703000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 108382642 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 108382642 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 108382642 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 108382642 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 24 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 35 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 118 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 222 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 20 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 8458 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 8877 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 276288 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 90415 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 14353 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 601727 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 261 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 100374 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 1083418 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 40842 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.2550 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0835 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.0132 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.5554 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0002 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.0927 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 14888000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.1412 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 9754000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0925 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 7824000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0742 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 5671000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0537 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 4912000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0466 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 4038000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0383 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 2935000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0278 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |